Alpha Tau Medical DRTS outlined a series of clinical and regulatory updates during the Lytham Partners Spring 2026 Investor Conference, with Raphi Levy of Alpha Tau telling investors the company’s most important trials are “coming to a head” over the coming months.
Read more here.
![[Appdome in SME Street] Appdome Enhances MOBILE Bot Defense for Web App Firewalls](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
